These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5528753)

  • 1. Genetic control of phenylbutazone metabolism in man.
    Whittaker JA; Evans DA
    Br Med J; 1970 Nov; 4(5731):323-8. PubMed ID: 5528753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic control of drug levels in man: phenylbutazone.
    Vesell ES; Page JG
    Science; 1968 Mar; 159(3822):1479-80. PubMed ID: 5753556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetanilide oxidation in phenylbutazone-associated hypoplastic anaemia.
    Cunningham JL; Leyland MJ; Delamore IW; Evans DA
    Br Med J; 1974 Aug; 3(5926):313-7. PubMed ID: 4411815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of drug levels in man: antipyrine.
    Vesell ES; Page JG
    Science; 1968 Jul; 161(3836):72-3. PubMed ID: 5690279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of dicumarol levels in man.
    Vesell ES; Page JG
    J Clin Invest; 1968 Dec; 47(12):2657-63. PubMed ID: 4177776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentration, mammary excretion and side-effects of phenylbutazone after repeated oral administration in healthy cows.
    Martin K; Andersson L; Stridsberg M; Wiese B; Appelgren LE
    J Vet Pharmacol Ther; 1984 Jun; 7(2):131-8. PubMed ID: 6748155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone.
    Gupta KC; Joshi JV; Hazari K; Pohujani SM; Satoskar RS
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):511-3. PubMed ID: 7174153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: the role of genetic factors.
    Andreasen PB; Froland A; Skovsted L; Andersen SA; Hauge M
    Acta Med Scand; 1973 Jun; 193(6):561-4. PubMed ID: 4738705
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug metabolism in normal children, lead-poisoned children, and normal adults.
    Alvares AP; Kapelner S; Sassa S; Kappas A
    Clin Pharmacol Ther; 1975 Feb; 17(2):179-83. PubMed ID: 804369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man.
    Neuvonen PJ; Elonen E
    Eur J Clin Pharmacol; 1980 Jan; 17(1):51-7. PubMed ID: 7371700
    [No Abstract]   [Full Text] [Related]  

  • 13. The biotransformation of phenylbutazone (Butazolidin).
    Faigle JW; Dieterle W
    J Int Med Res; 1977; 5 Suppl 2():2-14. PubMed ID: 410685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species.
    Kitagawa H; Kamataki T; Yoshida S
    Chem Pharm Bull (Tokyo); 1968 Dec; 16(12):2320-3. PubMed ID: 4975994
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylbutazone: factors influencing plasma concentrations.
    Davies DS
    J Int Med Res; 1977; 5 Suppl 2():15-9. PubMed ID: 913869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone.
    Kellermann G; Luyten-Kellermann M; Horning M; Stafford M
    Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative drug metabolism and inducibility by phenobarbital in sickle cell anemia.
    Anderson KE; Peterson CM; Alvares AP; Kappas A
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):580-7. PubMed ID: 913026
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
    Van Peer A; Belpaire F; Bogaert M
    Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.